Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02279173
What this trial is testing

Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Amgen 203
Early research (Phase 1)Not Yet RecruitingNCT07622329
What this trial is testing

A Clinical Study to Evaluate JCXH-213 in the Treatment of Adults With Primary Immune Thrombocytopenia

Who this might be right for
Thrombocytopenic Purpura, Immune
The General Hospital of Western Theater Command 4
Testing effectiveness (Phase 2)UnknownNCT05943691
What this trial is testing

High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Who this might be right for
ITP - Immune Thrombocytopenia
Shandong University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05023915
What this trial is testing

Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 106
Early research (Phase 1)Study completedNCT00774358
What this trial is testing

Interleukin-2 Treatment for Wiskott-Aldrich Syndrome

Who this might be right for
Wiskott-Aldrich Syndrome (WAS)X-linked Thrombocytopenia
Soma Jyonouchi 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07057778
What this trial is testing

Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Peking University People's Hospital 120
Large-scale testing (Phase 3)Study completedNCT02063789
What this trial is testing

An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Green Cross Corporation 81
Very early researchLooking for participantsNCT07441525
What this trial is testing

UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases

Who this might be right for
Autoimmune Hemolytic AnemiaPrimary Immune Thrombocytopenic PurpuraEvans Syndrome
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 27
Not applicableStudy completedNCT04350164
What this trial is testing

Romiplostim Treatment for Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome.

Who this might be right for
Wiskott-Aldrich Syndrome
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 67
Large-scale testing (Phase 3)Not Yet RecruitingNCT07051915
What this trial is testing

The Holistic Study

Who this might be right for
Thrombocytopenia Purpura
Ostfold Hospital Trust 220
Testing effectiveness (Phase 2)Ended earlyNCT01129024
What this trial is testing

An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Shionogi 19
Testing effectiveness (Phase 2)UnknownNCT04516837
What this trial is testing

Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 120
Not applicableStudy completedNCT01666795
What this trial is testing

Autoantibody Specificity and Response to IVIG in ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Shandong University 672
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07738822
What this trial is testing

A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA

Who this might be right for
Immune Thrombocytopenia (ITP)Warm Autoimmune Hemolytic Anemia (WAIHA)
Cullinan Therapeutics Inc. 72
Not applicableNot Yet RecruitingNCT06790888
What this trial is testing

Ripertamab Plus Eltrombopag vs. Eltrombopag in ITP Patients Post-Steroid Failure

Who this might be right for
ITP - Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 78
Large-scale testing (Phase 3)Study completedNCT04687072
What this trial is testing

Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
argenx 207
Testing effectiveness (Phase 2)UnknownNCT02338414
What this trial is testing

An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Samsung Medical Center 20
Not applicableStudy completedNCT01974232
What this trial is testing

A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013

Who this might be right for
Immune Thrombocytopenia
Weill Medical College of Cornell University 33
Early research (Phase 1)Looking for participantsNCT06826430
What this trial is testing

Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia

Who this might be right for
Autoimmune Thrombocytopenia
Juventas Cell Therapy Ltd. 12
Testing effectiveness (Phase 2)Looking for participantsNCT06531018
What this trial is testing

Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.

Who this might be right for
Primary Immune Thrombocytopenia
Renata PLC 100
Next Page